Sugi Predict

Sugi Predict / Compounds / SCHEMBL29636368

SCHEMBL29636368

SCHEMBL29636368

CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 2/20 0.53
▸ RAMP3 O60896 12/20 0.48
▸ CALCR P30988 12/20 0.48
▸ C5AR1 P21730 1/20 0.46
▸ CXCR4 P61073 1/20 0.44
▸ MAPK8 P45983 1/20 0.44
▸ MAPK9 P45984 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ APLNR P35414 1/20 0.44
▸ PLK1 P53350 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29636364 0.94 EPHA2 (0.51) EPHA2RAMP3CALCRC5AR1PLK1
SCHEMBL29636362 0.93 EPHA2 (0.51) EPHA2RAMP3CALCRC5AR1CXCR4
SCHEMBL31313242 0.90 EPHA2 (0.52) EPHA2RAMP3CALCR
SCHEMBL30327366 0.90 RAMP3 (0.48) EPHA2RAMP3CALCRC5AR1CXCR4
SCHEMBL29427923 0.89 EPHA2 (0.49) EPHA2RAMP3CALCRMAPK8MAPK9
SCHEMBL31307235 0.88 RAMP3 (0.57) EPHA2RAMP3CALCRMAPK8MAPK9
SCHEMBL29886811 0.88 EPHA2 (0.45) EPHA2RAMP3CALCRC5AR1MAPK8
SCHEMBL31462085 0.87 NTSR2 (0.47) EPHA2MAPK8MAPK9MAPK10
SCHEMBL11116638 0.87 RAMP3 (0.53) EPHA2RAMP3CALCRCXCR4
SCHEMBL11116645 0.87 RAMP3 (0.53) EPHA2RAMP3CALCRCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3187508-B1 LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF BIOMARIN PHARM INC (US) 2026-04-22 — — EP disclosed
US-20230241187-A1 Lysosomal Targeting Peptides and Uses Thereof BIOMARIN PHARMACEUTICAL INC. 2023-08-03 — — US disclosed
US-20220354934-A1 Lysosomal Targeting Peptides and Uses Thereof BIOMARIN PHARMACEUTICAL INC. 2022-11-10 — — US disclosed
US-11351231-B2 Lysosomal targeting peptides and uses thereof BIOMARIN PHARMACEUTICAL INC. (US) 2022-06-07 — — US disclosed